Osteoporosis News

ATLANTA — In this video exclusive, Bo Abrahamsen, MD, PhD, professor and consultant endocrinologist at the Institute of Clinical Research, University of Southern Denmark in Odense, and Holbæk Hospital, Denmark, describes the influence of treatment duration and adherence on risk for osteonecrosis of the jaw or oral cavity in patients noted to be adherent, long-term users of oral bisphosphonates for osteoporosis.

Nearly 3 dozen bone health-related organizations have issued a joint “call to action” to increase the screening, diagnosis and treatment of individuals at high risk for fractures, the president of the American Society for Bone and Mineral Research announced during the organization’s annual meeting.

ATLANTA — In this video exclusive, Sundeep Khosla, MD, professor of medicine and physiology at Mayo Clinic in Rochester, Minnesota, discusses his work involving sex steroids, coupling and age-related bone loss over 3 decades and offers some clinical implications of the findings.

The development of the cathepsin K inhibitor, odanacatib, for the treatment of osteoporosis has been discontinued, according to a press release from Merck.

Nearly 75% of patients who were using at least one medication that increased their fracture risk did not have that drug reduced following a fragility fracture, according to data published in JAMA Internal Medicine.

Compared with placebo, use of subcutaneous abaloparatide reduced the risk of new vertebral and nonvertebral fractures among postmenopausal women with osteoporosis during a period of 18 months, according to results.

Investigators of this study found cortical bone thickness measurements from standard ankle radiographs were strongly associated with dual X-ray absorptiometry results, demonstrating cortical bone thickness measurement may be an efficient screening tool for osteoporosis.

Bone Biologics announced it has signed an option agreement with the University of California, Los Angeles to exclusively license the bone growth factor Nell-1 in the treatment of osteoporosis.

Although hip fractures often signify the presence of osteoporosis, most older adults who experience hip fracture are not told they have osteoporosis, according to results.

DESTIN, Fla. – New drugs and more effective physician-to-patient communication are critical in the treatment of osteoporosis, according to a speaker at the Congress of Clinical Rheumatology.